Dexcom (DXCM) Accounts Payables (2011 - 2012)

Dexcom's (DXCM) quarterly Accounts Payables came in at $3.9 million in Q4 2012, up 39.29% year-on-year from $2.8 million in Q1 2012, and up 2.74% on a QoQ basis from $3.8 million in Q3 2012.

Dexcom (DXCM) Accounts Payables (2011 - 2012) Analysis & Trends

Dexcom (DXCM) has 2 years of Accounts Payables data on file, last reported at $3.9 million in Q4 2012.

  • On a quarterly basis, Accounts Payables rose 39.29% year-over-year to $3.9 million in Q4 2012; TTM through Dec 2012 was $3.9 million, a 39.29% increase from a year earlier, with the FY2012 full-year figure at $3.9 million, up 39.29% from the prior year.
  • Accounts Payables for Q4 2012 stood at $3.9 million, up from $3.8 million in the prior quarter.
  • Over the last five years, Accounts Payables for DXCM reached as high as $3.9 million in Q4 2012 and fell as low as $2.0 million in Q2 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 4.68 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 1.59 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 2.64 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.14 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 181.10 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 2.33 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 3.41 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 1.18 Bn
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 338.80 Mn

Historic Data

Download Data
DateValue
Dec 31, 2012 3.90 Mn
Sep 30, 2012 3.80 Mn
Jun 30, 2012 2.02 Mn
Dec 31, 2011 2.80 Mn